A boron nitride particle having a shell part formed of boron nitride and a hollow part surrounded by the shell part, in which a density of the boron nitride on an inside of the shell part is higher than a density of the boron nitride on an outside of the shell part. A resin composition containing the boron nitride particle and a resin. A method for producing a resin composition including a step of preparing the boron nitride particle and a step of mixing the boron nitride particle with a resin.

A boron nitride particle having a shell part formed of boron nitride and a hollow part surrounded by the shell part, in which a density of the boron nitride on an inside of the shell part is higher than a density of the boron nitride on an outside of the shell part. A resin composition containing the boron nitride particle and a resin. A method for producing a resin composition including a step of preparing the boron nitride particle and a step of mixing the boron nitride particle with a resin.

Disclosed herein are processes for purifying as-synthesized boron nitride nanotube (BNNT) material to remove impurities of boron, amorphous boron nitride (a-BN), hexagonal boron nitride (h-BN) nanocages, h-BN nanosheets, and carbon-containing compounds. The processes include heating the BNNT materials at different temperatures in the presence of inert gas and a hydrogen feedstock or in the presence of oxygen.

The present invention relates to a method for treating a sample using glow-discharge plasma, in an apparatus comprising a treatment vessel, an electrode, a counter-electrode, and a power supply comprising one or more transformers and having a first transformer setting and a second transformer setting, the method comprising: (i) a loading step, involving loading the sample into the treatment vessel; (ii) a first treatment step involving treating the sample in a glow-discharge plasma formed within the treatment vessel by applying an electric field between the electrode and counter-electrode at the first transformer setting; (iii) a second treatment step involving treating the sample in a glow-discharge plasma formed within the treatment vessel by applying an electric field between the electrode and counter-electrode at the second transformer setting; and (iv) a removal step, involving removing treated sample from the treatment vessel. The method can be used to functionalize a sample. The present invention also relates to an apparatus for use in such a method.

A polycrystalline cubic boron nitride comprising 99.5% by volume or more of cubic boron nitride, wherein the polycrystalline cubic boron nitride has a heat conductivity of 300 W/mK or more, the polycrystalline cubic boron nitride has a carbon content of 100 ppm or more and 1000 ppm or less in terms of mass, the polycrystalline cubic boron nitride comprises a plurality of crystal grains, and the plurality of crystal grains have a median diameter d50 of an equivalent circle diameter of 0.9 μm or more and 10 μm or less.

A polycrystalline cubic boron nitride comprising 99.5% by volume or more of cubic boron nitride, wherein the polycrystalline cubic boron nitride has a heat conductivity of 300 W/mK or more, the polycrystalline cubic boron nitride has a carbon content of 100 ppm or more and 1000 ppm or less in terms of mass, the polycrystalline cubic boron nitride comprises a plurality of crystal grains, and the plurality of crystal grains have a median diameter d50 of an equivalent circle diameter of 0.9 μm or more and 10 μm or less.

Provided herein is a nanopore structure, which in one aspect is a “carbon nanotube porin”, that comprises a short nanotube with an associated lipid coating. Also disclosed are compositions and methods enabling the preparation of such nanotube/lipid complexes. Further disclosed is a method for therapeutics delivery that involves a drug delivery agent comprising a liposome with a NT loaded with a therapeutic agent, introducing the therapeutic agent into a cell or a tissue or an organism; and subsequent release of the therapeutic agents into a cell.

Provided herein is a nanopore structure, which in one aspect is a “carbon nanotube porin”, that comprises a short nanotube with an associated lipid coating. Also disclosed are compositions and methods enabling the preparation of such nanotube/lipid complexes. Further disclosed is a method for therapeutics delivery that involves a drug delivery agent comprising a liposome with a NT loaded with a therapeutic agent, introducing the therapeutic agent into a cell or a tissue or an organism; and subsequent release of the therapeutic agents into a cell.

Presented here are nanocomposites and electrochemical storage systems (e.g., rechargeable batteries and supercapacitors), which are resistant to thermal runaway and are safe, reliable, and stable electrode materials for electrochemical storage systems (e.g., rechargeable batteries and supercapacitors) operated at high temperature and high pressure, and methods of making the same.

Presented here are nanocomposites and electrochemical storage systems (e.g., rechargeable batteries and supercapacitors), which are resistant to thermal runaway and are safe, reliable, and stable electrode materials for electrochemical storage systems (e.g., rechargeable batteries and supercapacitors) operated at high temperature and high pressure, and methods of making the same.